Abstract
We report the case of a 36-year-old woman who developed permanent hypoparathyroidism after thyroidectomy for differentiated thyroid carcinoma. A 6-year follow-up showed an increase of 11% in absolute bone mineral density at the spine and 6% at the hip accompanied by low bone turnover despite thyroid-stimulating hormone suppressive thyroxine therapy.
MeSH terms
-
Absorptiometry, Photon
-
Adult
-
Antacids / therapeutic use
-
Bone Density / physiology*
-
Bone Density Conservation Agents / therapeutic use
-
Bone Remodeling / physiology*
-
Calcitriol / therapeutic use
-
Calcium Carbonate / therapeutic use
-
Female
-
Femur / diagnostic imaging*
-
Follow-Up Studies
-
Humans
-
Hypoparathyroidism / etiology*
-
Lumbar Vertebrae / diagnostic imaging*
-
Premenopause
-
Thyroid Neoplasms / surgery
-
Thyroidectomy / adverse effects*
-
Thyroxine / therapeutic use
Substances
-
Antacids
-
Bone Density Conservation Agents
-
Calcitriol
-
Calcium Carbonate
-
Thyroxine